From the initial stages of compound screening to the detailed analysis of drug efficacy and safety, our IVP services integrate seamlessly into the drug development pipeline. Our sophisticated CDX (Cell-Derived Xenograft) models, which include living image cell lines, drug-resistant variants, and gene-edited lines, are meticulously designed to reflect the human biological response to novel treatments. These models serve as critical platforms for testing and refining anti-tumor agents, ensuring that only the most promising candidates move forward in the drug discovery process.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel:+86-10-67809840
Get a quote
Go top